March 25, 2023
MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update
Patient enrollment underway in Europe in ongoing Phase 2 trial in NSCLC (THIO-101) Outlined plan to initiate second Phase 2…
Clinical trial labels across the globe – how to manage translations and country specific regulations
In recent years, there has been an industry-wide recognition of the need for speed and agility. Accelerating the trial processes for COVID-19 vaccine candidates required proactive and cooperative efforts from...
November 14, 2022
Moderna’s biovalent booster candidates meet primary endpoint of superiority against Omicron variants in trai
Moderna said Monday that both of its bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger a superior antibody response compared to a booster dose of mRNA-1273, the Company's prototype vaccine,...
Allergan’s BOTOX Cosmetic Celebrates 20th Birthday
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating 20th anniversary of FDA's approval of Botox Cosmetic.
EMA and the EUnetHTA 21 consortium set priorities for their collaboration
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) 21 consortium have published a joint work plan until 2023....
Sanofi Launches First-In-Pharma Diversity, Equity & Inclusion Board
Sanofi has launched its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors....
